The central drug regulator the Central Drugs Standard Control Organisation (CDSCO) has informed the World Health Organisation (WHO) about the halt in the production of Coldrif, Respifresh TR and ReLife, which it has deemed toxic. The CDSCO has also communicated to the the global





